Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
82
days
AI-based prediction of actionable genomic alterations from H&E-stained slides
Authors
Woochan Hwang; Fernando Lopez-Rios; Kashif Firozvi; Vivek Subbiah; Siraj M. AliShow moreShow less
Affiliations
1. Department of Medicine, Mount Auburn Hospital, Cambridge, USA; 2. Lunit Inc, Seoul, Republic of Korea; 3. Department of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre (i + 12), CIBERONC, Madrid, Spain; 4. Maryland Oncology Hematology, Silver Spring, USA; 5. Division of Oncology, Stanford University School of Medicine, Palo Alto, USAShow moreShow less
217
days
Stromal VEGF-C expression predicts nodal metastasis: implications for axillary surgery de-escalation in breast cancer
Authors
Pauline Jeannot; Emelie Edvardsson; Oscar Hernquist; Cornelia Brandt; Linnea Fischhaber; Anna-Maria Larsson; Beatrice Öhlund; Kristian Pietras; Pär-Ola Bendahl; Charlotte Rolny; Lisa RydenShow moreShow less
Affiliations
1. Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden; 2. Lund University Cancer Centre, Lund University, Lund, Sweden; 3. Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden; 4. SciLifeLab, Department of Laboratory Medicine, Lund University, Lund, Sweden; 5. Department of Gastroenterology and Surgery, Skåne University Hospital, Malmö, Sweden; 6. CIRCE: Centre for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, SwedenShow moreShow less
61
days
Decoding small cell lung cancer vulnerabilities: the AI pathway to next-gen therapeutics
Authors
Mu Li; Lei Zhang; Zhenglun Yu; Jun Li; Shuo Wang; Simeng ZhangShow moreShow less
Affiliations
1. Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China; 2. Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, China; 3. Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China; 4. Department of Ophthalmology, The First Hospital of China Medical University, Shenyang, China; 5. Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, ChinaShow moreShow less
111
days
Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears
Authors
Jan-Niklas Eckardt; Chethan Babu V. Reddy; Andrew Srisuwananukorn; Christian Pohlkamp; Maryam Schübel; Ishan Srivastava; Miriam Stoerk; Sebastian Riechert; Tim Schmittmann; Martin M. K. Schneider; Klaus H. Metzeler; Karsten Spiekermann; Markus Badstübner; Susann Winter; Katja Sockel; Frank Kroschinsky; Christoph Röllig; Martin Bornhäuser; Tobias Herold; Torsten Haferlach; Ann-Kathrin Eisfeld; Jan Moritz MiddekeShow moreShow less
Affiliations
1. Department of Internal Medicine I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 2. Else Kröner Fresenius Center for Digital Health, TUD Dresden University of Technology, Dresden, Germany; 3. Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 4. Cancilico GmbH, Dresden, Germany; 5. Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, USA; 6. MLL Munich Leukemia Laboratory, Munich, Germany; 7. Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; 8. Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany; 9. German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 10. National Center for Tumor Diseases (NCT), NCT//UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 11. Department of Hematology, Oncology, and Stem-Cell Transplantation, Munich Hospital Bogenhausen, Munich Municipal Hospital Group, Munich, GermanyShow moreShow less
393
days
The promise and limits of patient-reported outcomes in molecular tumor board-guided care: toward a framework for patient-centered precision oncology
Authors
L. Gräßel; S. Yacob; C. Strantz; E. Prochaska; T. Debertshäuser; AA. Rogge; S. Bäcker; F. Prasser; P. Unberath; J. Wehrle; S. Jäger; M. Boerries; AL Illert; U. Lührig; M. WolfienShow moreShow less
Affiliations
1. Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany; 2. Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 3. Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 4. Institute for Medical Informatics and Biometry, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 5. Charité - Universitätsmedizin Berlin, Berlin Institute of Health @ Charité, Berlin, Germany; 6. Center for Patient-Centered Outcomes Research, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 7. Department of Psychosomatic Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 8. Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 9. SRH Fürth University of Applied Sciences, Fürth, Germany; 10. Data Integration Center, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Freiburg, Germany; 11. Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 12. Department I of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany; 13. Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI Dresden/Leipzig), Dresden, Saxony, GermanyShow moreShow less
236
days
An individual sample predictive model to classify patients with metastatic renal cell carcinoma
Authors
Anupama Reddy; W. Jared Brewer; Scott M. Haake; Brian RiniShow moreShow less
Affiliations
1. Vindhya Data Science, Morrisville, USA; 2. Vanderbilt University Medical Center, Nashville, USAShow moreShow less
FAQ
How long does npj Precision Oncology take to review a manuscript?
As of 2026-11-18, CrushSCI has 21 complete review records for npj Precision Oncology. The fastest paper went from submission to acceptance in 61 days (Decoding small cell lung cancer vulnerabilities: the AI pathway to next-gen therapeutics, received 2026-07-04, accepted 2026-09-03); the slowest took 393 days. The average is 202.7 days and the median is 205 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
